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ARTICLE OPEN
Hip load capacity cut-points for Astronaut Skeletal Health
NASA Finite Element Strength Task Group
Recommendations
Andrew S. Michalski1,2,3, Shreyasee Amin4,5, Angela M. Cheung6,7,8, Dianna D. Cody9, Joyce H. Keyak10,11,12, Thomas F. Lang 13,
Daniel P. Nicolella14, Eric S. Orwoll15, Steven K. Boyd16,17 and Jean D. Sibonga18
Concerns raised at a 2010 Bone Summit held for National Aeronautics and Space Administration Johnson Space Center led experts
in ﬁnite element (FE) modeling for hip fracture prediction to propose including hip load capacity in the standards for astronaut
skeletal health. The current standards for bone are based upon areal bone mineral density (aBMD) measurements by dual X-ray
absorptiometry (DXA) and an adaptation of aBMD cut-points for fragility fractures. Task Group members recommended (i) a
minimum permissible outcome limit (POL) for post-mission hip bone load capacity, (ii) use of FE hip load capacity to further screen
applicants to astronaut corps, (iii) a minimum pre-ﬂight standard for a second long-duration mission, and (iv) a method for
assessing which post-mission physical activities might increase an astronaut’s risk for fracture after return. QCT-FE models of eight
astronaut were analyzed using nonlinear single-limb stance (NLS) and posterolateral fall (NLF) loading conﬁgurations. QCT data
from the Age Gene/Environment Susceptibility (AGES) Reykjavik cohort and the Rochester Epidemiology Project were analyzed
using identical modeling procedures. The 75th percentile of NLS hip load capacity for fractured elderly males of the AGES cohort
(9537N) was selected as a post-mission POL. The NLF model, in combination with a Probabilistic Risk Assessment tool, was used to
assess the likelihood of exceeding the hip load capacity during post-ﬂight activities. There was no recommendation to replace the
current DXA-based standards. However, FE estimation of hip load capacity appeared more meaningful for younger, physically active
astronauts and was recommended to supplement aBMD cut-points.
npj Microgravity             (2019) 5:6 ; https://doi.org/10.1038/s41526-019-0066-3
INTRODUCTION
Skeletal changes with spaceﬂight have been known to exist since
early missions;1,2 however, a clinical risk for fracture or for
osteoporosis as a consequence of microgravity-induced bone loss
is not readily seen. Since the completion of the International Space
Station (ISS) in 2000 and with the increased duration of future
spaceﬂights, some of which are planned beyond low Earth orbit,
National Aeronautics and Space Administration (NASA) has been
concerned with microgravity-induced bone loss3–6 and its effects
on skeletal integrity after the return from ﬂight.7–9 Spaceﬂight is
known to induce declines in hip load capacity,10 which may
increase the factor of risk for hip fracture (where applied
mechanical loads> bone load capacity). Therefore, it is plausible
that a fracture could occur during the performance of activities
(either during or after ﬂight) that would otherwise be unlikely
before spaceﬂight.
Astronaut bone health medical standards are established to set
operating bands (acceptable ranges) of bone health measure-
ments in the long-duration astronauts. These operating bands of
astronaut skeletal health are an adaptation of guidelines
formulated by the World Health Organization (WHO) to diagnose
primary osteoporosis, a condition of skeletal fragility due to aging
that predisposes humans to low trauma fractures. The WHO
guidelines are based upon measurements of areal bone mineral
density (aBMD) at the hip by dual X-ray absorptiometry (DXA).
Spine skeletal health is also of concern, but modiﬁcations to those
standards are beyond the scope of this investigation. A pathway
for using pre- and post-ﬂight DXA testing to drive the protection
of astronaut skeletal health is outlined in Fig. 1a, b, respectively.
Based on current medical standards, an astronaut is certiﬁed for
long-duration spaceﬂight by a pre-ﬂight hip aBMD measurement
of 1 SD below the mean young sex-matched population reference
aBMD (i.e., T-score ≥− 1.0) or greater. An astronaut’s post-ﬂight
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acceptable aBMD cut-point (the “permissible outcome limit”=
POL) is a T-score ≥− 2.0. Hence, effective countermeasures are
aimed at maintaining aBMD consistent with the POL and post-
ﬂight rehabilitation is targeted to restore aBMD to baseline levels
(within the measurement error of the DXA test).11
As the WHO guidelines were originally developed from and for
a population with age-related bone loss, NASA convened experts
in osteoporosis and bone densitometry in Houston, TX, USA, for a
NASA Bone Summit. A goal for the Bone Summit was to solicit
opinions on the assessment of skeletal health in the younger-aged
astronauts before and after spaceﬂight. After an in-depth review
of biomedical and research data from astronauts exposed to long-
duration spaceﬂight, the members of the Bone Summit high-
lighted the inability of DXA measurements to capture the full
effects of spaceﬂight12 and expressed concern that the sole
measurement of aBMD was insufﬁcient for understanding space-
induced changes to skeletal health, particularly for this under-
studied (younger, active, predominantly male) population
exposed to a unique skeletal insult. Notably, DXA has multiple
limitations (e.g., two-dimensional measurement, poor geometric
representation, and lack of compartmental and micro-architecture
characterization).13–16 Consequently, to maintain the astronaut’s
Fig. 1 a Current pre-ﬂight standard operating procedure for skeletal assessment. b Current post-ﬂight standard operating procedure for
skeletal assessment. R refers to time point for return from mission
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high standard of skeletal health, the current clinical test (DXA) for
osteoporosis needs to be expanded and state-of-the-art technol-
ogies may need to be used, to provide a comprehensive detection
of spaceﬂight-induced changes to the hip and a greater under-
standing of how those changes inﬂuence hip bone load capacity.
The experts suggested that NASA investigate using estimates of
hip bone load capacity—from the analysis of quantitative
computed tomography (QCT)-derived ﬁnite element (FE) models
—to interpret and assess the skeletal health status of current
astronauts and potential astronaut candidates.
FE models incorporate multiple determinants of bone load
capacity, including density, geometry, and size. In addition,
prospective studies have documented that both QCT and FE
modeling can independently assess hip fracture risk in compar-
ison with DXA aBMD alone.17–22 Without incorporating additional
QCT assessment of skeletal health, NASA is at risk of inadequately
observing skeletal changes with spaceﬂight and recovery, poorly
estimating countermeasure efﬁcacy, and not identifying at-risk
crewmembers that may require further skeletal protection.23,24
Following the review of both astronauts’ clinical and biomedical
research data, summit members noted that DXA technology for
BMD measurements did not detect all the skeletal changes, as
detected by QCT. Even though there are no clinical guidelines
associated with QCT measurements, the data acquired describe
profound skeletal changes that should be monitored as the utility
of those measurements are being deﬁned.12 Consequently, it was
perceived that estimations of hip bone load capacity by QCT-FE
modeling could help describe spaceﬂight effects on a function
(i.e., the hip resistance to fracture under speciﬁcally oriented
applied loading).12 Moreover, there is ongoing application of QCT-
FE modeling to terrestrial population studies20,21,25,26 to establish
clinical guidelines. Consequently, the Bone Discipline in the NASA
Human Research Program explored how FE modeling could be
used to set skeletal health standards for astronauts.
To this aim, the FE Strength Task Group I (2011) was convened,
which was composed of investigators who have applied QCT-FE
modeling in terrestrial studies of aging populations. The FE
Strength Task Group I recommended that a dataset be developed
of QCT-FE hip load capacity estimates from subjects whose ages
span the range of active astronauts (35–55 years). For these
speciﬁc purposes, QCT hip scans from population studies were
donated by members of this Task Group I, who either served as or
acted on behalf of the principal investigators of the studies. A
single FE modeling approach was applied to all hip QCT scans to
ensure consistency in hip bone load capacity estimations. In 2016,
FE Strength Task Group II was convened to review FE data from
combined population studies27–29 and to recommend the hip load
capacity cut-points to establish operating bands of astronaut
health. These proposed FE load capacity cut-points would
complement the DXA aBMD-based T-scores currently used as
the NASA standard for astronaut skeletal health.
In this report, the FE Strength Task Group II recommends use of
QCT-FE cut-points to establish (i) a minimum FE estimate of hip
load capacity after a mission as a POL, (ii) an additional skeletal
health index to qualify an applicant for astronaut candidacy for
further medical screening, (iii) a minimum ﬁtness-for-ﬂight
standard for second long-duration mission, and (iv) an index by
which ﬂight surgeons could assess whether certain post-mission
physical activities might increase the astronaut’s risk factor for
fracture. Application of these FE-based standards of bone health
with ﬂight data from astronauts (n= 8) are demonstrated.
RESULTS
Population-derived FE load capacity cut-points
Demographic data for all cohorts used in the data analysis can be
referenced in Table 1. FE analysis was implemented using
nonlinear material properties for the models.29 Population data
from the nonlinear single-limb stance (NLS) and nonlinear
posterolateral fall (NLF) FE analyses are presented in Fig. 2a, b,
respectively. All astronaut data are represented at a single age
point and ﬂight duration to ensure data are non-identiﬁable. As
per Task Group assessments, a 75th percentile cut-point, as
determined from the Age Gene/Environment Susceptibility (AGES)
Reykjavik male fractured cohort, was selected as the POL. The 75th
percentile for NLF FE load capacity was 3664N and the NLS FE load
capacity 9537N. The 75th percentile, vs. the mean or median load
capacity of the AGES cohort, sets a higher standard for counter-
measure efﬁcacy and for skeletal protection in the younger-aged
astronaut with many lifetime years remaining. For the stance
loading conﬁguration, the pre-ﬂight and post-ﬂight data of
astronauts (n= 8 tested) both exceeded the FE load capacity
POL. For the fall loading conﬁguration, the hip load capacity of
one astronaut falls below this POL cut-point before spaceﬂight
and hip load capacities for three astronauts fall below the POL cut-
point after spaceﬂight. Data included show, on average, that
astronaut pre-ﬂight (NLS: 14279 ± 3673N) and post-ﬂight (NLS:
13624 ± 3215N) hip load capacities are signiﬁcantly greater (p <
0.05) than the population mean (NLS: 11416 ± 2816N) for a subset
of the Mayo cohort (ages 27–55 years). Figure 3 depicts
correlations between the DXA T-Scores and FE outcomes for the
Mayo cohort and the astronaut cohorts (combined pre- and post-
ﬂight outcomes). The population DXA data are moderately
correlated and statistically signiﬁcant with the FE estimated NLS
(R2= 0.77, p < 0.001) and NLF (R2= 0.63, p < 0.001) hip load
capacities. The astronaut DXA data are poorly correlated with
the NLS (R2= 0.13, p > 0.05) and NLF (R2= 0.43, p < 0.01) load
capacities, where the NLS correlation is not statistically signiﬁcant
(Table 2).
An assessment tool for bone health
Figure 4a, b illustrate how the combined cut-points would
differentiate skeletal health in the younger-aged terrestrial Mayo
population and the astronaut cohort. Cut-points include the
proposed FE-derived hip load capacity (NLS= 9537N and NLF=
3664N) relative to the DXA T-score of −1.0. These charts propose
an additional metric to DXA T-score for screening bone health in
Table 1. Cohort information for the AGES, Mayo, and astronaut
cohorts
AGES cohort Non-fractured cases Fracture cases
N 94 45
Age (years) 79.6 ± 5.2 (70.0–90.0) 80.3 ± 5.7 (71.0–93.0)
Height (cm) 174.9 ± 6.7 (162.4–190.5) 175.1 ± 5.5 (159.2–187.1)
Body weight (kg) 82.6 ± 14.8 (52.4–135.0) 80.1 ± 14.4 (50.3–114.0)
Mayo cohort Males Females
N 181 216
Age (years) 59.9 ± 16.6 (28.0–90.0) 60.9 ± 14.5 (27.0–90.0)
Height (cm) 176.3 ± 7.2 (157.0–195.4) 162.3 ± 6.1 (148.5–179.2)
Body weight (kg) 90.2 ± 16.5 (53.0–134.0) 74.4 ± 15.4 (51.0–128.5)
Astronauts
N 8 (Males= 6, females= 2)
Age (years) 46.0 ± 5.0 (38.0–53.0)
Height (cm) 176.0 ± 5.0 (168.0–180.0)
Body weight (kg) 72.0 ± 12.0 (59.0–88.0)
Duration of ﬂight (days) 154.0 ± 19.0 (125.0–169.0)
All values presented as mean ± SD (range)
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applicants to the astronaut corps who fail to meet the bone
medical standard of hip T-score >−1.0.
DISCUSSION
Review of current astronaut skeletal health standards
In terrestrial medicine, the probability of fracture in the population
at risk for age-related bone loss11,30,31 undergirds the WHO criteria
for interventions at BMD T-scores <−2.5 for the hip, spine, or
wrist.32 The WHO DXA T-score guidelines have minimal value for
applicants for astronaut candidacy and for many active astronauts
because of their age-range (35–55 years). The WHO DXA guide-
lines were never intended to assess a population experiencing
bone loss due to prolonged spaceﬂight. To date,11 all astronauts
have returned from missions on the ISS with BMDs above the POL
(T-score=−2.0 SD). However, the use of T-scores alone may
inadequately characterize any risks associated with rapid and
signiﬁcant BMD losses (10–15%15) observed after spaceﬂight.
Furthermore, these data suggest that the POL standard is not
sensitive for monitoring the efﬁcacy of in-ﬂight countermeasures
since astronauts were meeting the standard before mitigation of
bone loss by on-orbit use of bisphosphonates or the Advanced
Resistive Exercise Device (ARED) was observed.33,34
As previously identiﬁed at the Bone Summit, DXA fails to detect
changes to cortical and trabecular sub-regions of the hip.12 DXA is
limited by the two-dimensional nature of the imaging modality,
which lacks the ability to accurately characterize bone size and
geometry. DXA’s also averages total bone mass35 across bone
compartments, where the highly dense mineral in cortical obscure
any changes to trabecular bone mass. In terrestrial studies, these
limitations contribute to the poor predictability of fragility fractures
in both men and women, who have not reached the diagnostic
BMD cut-point for osteoporosis.36 Unlike elderly subjects, young
individuals, such as the astronaut cohort, are more likely to fracture
due to excessively overloading their bones caused by sports or
other trauma,37,38 rather than osteoporosis, which reduces the
utility of WHO guidelines32 for the astronaut cohort.
Following the review of astronaut biomedical data, both
research and clinical, Bone Summit experts additionally recom-
mended that an index of skeletal integrity (e.g., bone load
capacity) could be serially evaluated in long-duration astronauts
and may enhance the evaluation of astronaut eligibility. The
effects of microgravity on bone integrity are not well understood
and require more thorough evaluation. However, in a position
development by the International Society of Clinical Densitometry
(ISCD), QCT-FE has been identiﬁed as a rigorous and repeatable
approach to obtain a composite assessment of bone integrity39
and has been recommended by the ISCD for use to monitor
changes in skeletal health related to age or treatment,40,41 in
addition to DXA. This study suggests that, because FE estimates of
hip load capacity integrates biomechanics in its evaluation, it likely
has utility for assessing skeletal health in the physically active
astronaut, after spaceﬂight.
The standard development of clinical practice guidelines for
bone health in terrestrial medicine considers a multitude of data
from large population studies with fracture outcomes. The
astronauts, in contrast, represent an understudied target popula-
tion for bone loss (physically ﬁt, healthy, predominantly male,
exposed to spaceﬂight) for which there are limited baseline data.
Group mean data from astronauts can also be confounded by
large variations in subject-speciﬁc characteristics, including age,
training, ﬂight duration, and ﬂight conditions. Although DXA offers
an epidemiological approach using BMD T-scores to convey a
relative risk for fracture, these T-scores do not identify who will
fracture. The FE bone load capacity may be a more meaningful
measure for evaluating the astronaut after spaceﬂight, because
QCT-FE facilitates an individualized biomechanical risk assessment
of hip fractures that is speciﬁc to the astronaut’s geometry, bone
density distribution, bone size, and shape of the hip. As exhibited
in Fig. 3b, astronauts may have similar hip load capacities but
highly variable DXA T-scores. This observation is even more
apparent in the Mayo cohort data (Fig. 3a), suggesting that the
variability from using DXA is greater than the variability and
precision expected of QCT-FE. By incorporating this new index for
skeletal health that integrates more skeletal attributes inﬂuenced
by spaceﬂight, a customized risk management plan can be
developed speciﬁc to each astronaut. There is a potential for
enhancing the assessment of fracture risk probabilities and the
management of spaceﬂight-induced bone loss.
Recommendation 1
The FE Strength Task Group recommends using QCT-FE data from
population studies to assess overall skeletal health of the hip in
astronauts. Based upon the analysis of population fracture data, a
POL of 9537N for the hip in the NLS loading conﬁguration is
Fig. 2 a Nonlinear stance subject data with age and FE load
capacity, the dashed line represents the 75th percentile FE load
capacity cut-point at 9537N. b Nonlinear fall population data with
age and FE load capacity, the dashed line represents the 75th
percentile FE load capacity cut-point at 3664N. The 75th percentile is
deﬁned from the AGES male fracture cohort. Astronaut data are
represented at a single time point to maintain non-identiﬁable data
A.S. Michalski et al.
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recommended. This FE load capacity cut-point should be used as
an additional pre- and post-ﬂight skeletal health index to evaluate
astronauts. Furthermore, this FE load capacity cut-point is
applicable for both male and female astronauts. The same POL
should also be used as a minimum standard to measure
countermeasure efﬁcacy for astronauts.
A previous study used the WHO T-score classiﬁcations to
determine FE interventional cut-points—for a sideways fall hip
loading conﬁguration22—which were equivalent to osteoporotic
BMD classiﬁcation (3000N for women and 3500N for men),
thereby allowing for a clinical interpretation of FE hip load
capacity. However, just as with DXA T-scores in young humans,32
intervention cut-points are driven by fracture probability and
fractures in the elderly population are not equivalent to fractures
in young, healthy persons.37 In addition, the FE Strength Task
Group II recommends using a single cut-point for both male and
female astronauts, not only for ease of implementation but to hold
NASA to a higher standard for protecting skeletal health. On
average, women have lower FE estimated hip load capacity,
presumably due to menopause-induced bone loss and smaller
bones, leading to an inherent fracture risk at lower applied loads
to hip. Based upon observations of the Mayo cohort in Fig. 2, it is
not unreasonable to hold female astronauts to this criterion, as
many young females in this terrestrial cohort exceed the 75th
percentile cut-point.
Previous spaceﬂight work shows that DXA may not capture all
the changes that occur in bones during spaceﬂight. Lang et al.15
showed higher rates of bone loss in the trabecular compartment,
as measured by QCT, compared with the DXA rates of total bone
loss in the hip. Furthermore, using QCT, Carpenter et al.42
demonstrated that vertebral trabecular volumetric bone mineral
density (vBMD) remained lower than pre-ﬂight values after 2–4
years of recovery, whereas DXA vertebral aBMD showed a
recovery in bone density for the identical astronauts. A recent
study has shown that tibial cortical porosity and trabecular BMD,
as measured by high-resolution peripheral QCT, fail to recover
after a year from returning from spaceﬂight.43 Spaceﬂight-induced
bone loss persisting after return to Earth could combine with age-
related bone loss and prematurely increase the fracture risk for
astronauts later in life.
The FE Strength Task Group recommends that the FE load
capacity POL be used as an additional standard for counter-
measure efﬁcacy (e.g., ARED exercise prescriptions). In terrestrial
populations, the ISCD highlights the use of QCT-FE40,41 to monitor
changes in bone health and load capacity. Terrestrial studies also
show that exercise induces changes in bone size,44 which are
Fig. 3 a Correlation data for the Mayo cohort between DXA T-score and NLS FE outcomes. R2= 0.77. b Correlation data for the astronaut
cohort between DXA T-score and NLS FE outcomes. Pre- and post-ﬂight data are analyzed as a combined set. R2= 0.13. c Correlation data for
the Mayo cohort between DXA T-score and NLF FE outcomes. R2= 0.63. d Correlation data for the astronaut cohort between DXA T-score and
NLF FE outcomes. Pre- and post-ﬂight data are analyzed as a combined set. R2= 0.43
A.S. Michalski et al.
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detected by QCT and not DXA; these changes are incorporated
into QCT-FE models, suggesting greater sensitivity for detecting
the effects of exercise.
Recommendation 2
The NASA Probabilistic Risk Assessment (PRA) model for fracture
probabilities can be used to assess fracture likelihoods for both
mission-speciﬁc tasks and post-mission activities. A model of linear
bone deconditioning may be convenient for assessing fracture
probabilities with varying durations of spaceﬂight exposures but
efforts to develop a physiologically relevant model for skeletal
deconditioning over time are warranted for this rare and unique
skeletal insult. The combination of FE models to estimate hip load
capacity and the PRA model to assess the range of physical
activities that might mechanically overload the hip could have
clinical utility for managing fracture risk in physically active
persons.
Risk assessment in terrestrial populations is performed using
speciﬁc risk assessment tools (e.g., FRAX), which integrate multiple
determinants and risk factors for fracture, including BMD, to assess
fracture probability and eligibility for treatment.45 However, these
fracture risk assessment tools fail to integrate bone loss due to
spaceﬂight or prolonged disuse and are not grounded in data
from younger individuals. There is currently no fracture risk
assessment tool that incorporates QCT-FE outcomes. Nevertheless,
QCT-FE has been used for fracture prediction in terrestrial cohorts.
The nonlinear stance analysis used in this work has improved
fracture prediction (NLS R2= 0.82, NLF R2= 0.53) for both men
and women, compared with the nonlinear fall loading conﬁgura-
tion.29 Therefore, the FE Strength Task Group II recommends the
use of the NLS loading conﬁguration for a skeletal health standard
to monitor hip biomechanical integrity in astronauts. In contrast,
the NLF loading conﬁguration is a conditional loading conﬁgura-
tion, which requires a fall to the hip for the analysis to be relevant;
even if a fall occurs, the impact force of may differ from the NLF
loading condition.
NASA previously determined a standardized PRA methodology,
to establish mission-speciﬁc fracture risk from loading scenarios,
including a fall on the hip.46 PRA uses a biomechanical model of a
sideways fall on the hip to estimate a probability distribution of an
overloading fracture. The biomechanical model incorporates
multiple parameters, including gravitational forces and mission-
speciﬁc parameters that contribute to skeletal loading.46 Com-
bined with the NLF FE data, PRA incorporates a distribution of
applied loads at the hip (Fig. 5a) for mission-speciﬁc tasks or post-
mission activities, to determine the hazard risk for fracture with
low- and high-energy falls. Based on Monte Carlo simulation, load
distributions for missions to the ISS, Moon, and Mars have been
included to compare with loads after return to Earth. Fracture risk
in younger persons is mainly due to excessive force on the bone,37
which would be the primary concern for astronauts prematurely
resuming activities with the potential for high forces (e.g., playing
contact football, skydiving). For low-force events (Fig. 5a), there is
a probability of 0.13 for bone overload using the NLF load capacity
cut-point. Using PRA and the NLF FE load capacity cut-point (Fig.
5b), there is a probability of 0.67 for bone overload for high-force
events using the NLF load capacity cut-point. The large reported
probabilities for overloading are due to the high loading levels
associated with the high-energy activities. The FE Strength Task
Group II recommends using the NLF FE load capacity of individual
astronauts to assess probabilities of hip fractures during the
performance of in-mission tasks and of post-mission activities.46
Based on load distributions for various missions, there is little to
no risk of experiencing an overloading fracture during the
microgravity missions to the ISS, the Moon, or Mars. However,
these probabilities do not account for any associated physiological
deconditioning with long-duration spaceﬂight (e.g., muscle
atrophy), which can increase the risk for falls.
Recommendation 3
There are no new recommendations for qualifying applicants for
astronaut candidacy or for certifying astronauts for their maiden
spaceﬂight missions. The current NASA standard of a DXA T-score
>−1.0 for the hip should remain the acceptable criterion for pre-
ﬂight skeletal health. However, because DXA technology cannot
detect all of the effects of spaceﬂight on bones, the FE Strength
Task Group recommends the inclusion of QCT-FE into the
standard operating procedures for assessing astronaut skeletal
health following prolonged space exposures. QCT-FE provides an
index that is complementary to DXA aBMD and an understanding
of how spaceﬂight affects hip integrity that DXA cannot. It was
suggested by NASA personnel that, because younger persons are
already at low risk for osteoporosis and fractures, even with aBMD
T-scores <−2.5, it is not equitable to screen applicants to
Table 2. DXA and QCT-FE results for the astronaut cohort
Astronaut cohort Pre-ﬂight Post-ﬂight
DXA scan time (days) 95 ± 34 (56–160) 8 ± 2 (5–11)
Total hip aBMD (g/cm2) 1.06 ± 0.13 (0.88–1.24) 1.03 ± 0.13 (0.83–1.20)
Total hip T-score 0.97 ± 1.04 (−0.48–2.46) 0.74 ± 1.07 (−0.95–2.11)
QCT scan time (days) 82 ± 26 (42–123) 10 ± 2 (6–14)
FNLS (N) 14279 ± 3673 (10,030–22,072) 13624 ± 3215 (10,757–20,914)
FNLF (N) 4037 ± 385 (3488–4590) 3925 ± 456 (3350–4486)
Total hip aBMD −0.03 ± 0.02 Total hip aBMD −2.73 ± 1.93
Absolute change (g/cm2) (−0.06–0.001) Relative change (%) (−6.39–0.10)
Total hip T-score −0.23 ± 0.15 Total hip T-score 15.28 ± 67.12
Absolute change (−0.46–0.01) Relative change (%) (−57.94–140.83)
FNLS −654.25 ± 1239.04 FNLS −3.63 ± 6.93
Absolute change (N) (−2106–1697) Relative change (%) (−14.90–16.92)
FNLF −111.50 ± 279.32 FNLF −2.74 ± 6.93
Absolute change (N) (−507–354) Relative change (%) (−12.49–8.64)
All values presented as mean ± SD (range). FNLS and FNLF refer to load capacities for the nonlinear stance and nonlinear fall loading conﬁgurations, respectively.
Absolute and relative changes are reported as change from pre-ﬂight values
A.S. Michalski et al.
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astronaut candidacy based exclusively upon a DXA test. QCT-FE
modeling for hip bone load capacity would provide a secondary,
science-based test to screen and authorize prioritized applicants,
with T-scores <−1.0 but >−1.5, to progress through medical
screening.
A proposed integration of QCT-FE into a standard operating
procedure for a crewmember’s pre-ﬂight skeletal assessment is
presented in Fig. 6a and for post-ﬂight assessment in Fig. 6b. The
integration of QCT-FE would provide a more comprehensive
assessment of skeletal health by providing additional indices,
including estimated bone load capacity and vBMD for separate
cortical and trabecular bone compartments that can change
profoundly with spaceﬂight.
Overall assessment
NASA is faced with the risks that the current clinical test (DXA)
cannot fully detect skeletal changes with spaceﬂight, recovery,
and may incompletely evaluate the efﬁcacy of countermeasures.
Due to these limitations, NASA may be inadequately assessing the
actual fracture risk of individual astronauts. Post-ﬂight risk
management could be enhanced by pre- and post-ﬂight QCT-FE
modeling, as it provides a biomechanical index for bone health
(i.e., the magnitude and orientation of mechanical loading that
would cause the hip to fracture). Through the use of Fig. 4, QCT
hip scans would be performed post-ﬂight for long-duration
astronauts to assess complete skeletal health recovery, within
measurement error, which is not currently feasible by DXA alone.
Although hip QCT scans would enable post-ﬂight monitoring of
full recovery, the FE analysis of QCT data also generates estimates
of hip load capacity that could be used to inform engineering
requirements for spacecraft or spacesuit designs, or to suggest
modifying physical activity levels, to reduce likelihood of over-
loading the hip. As more longitudinal spaceﬂight data are
Fig. 4 a Nonlinear stance clinical chart with T-score and FE load
capacity. The vertical dashed line represents the DXA clinical
standard at a T-score of −1.0 and the horizontal dashed line
represents the 75th percentile FE load capacity cut-point at 9537N. b
Nonlinear fall clinical chart with T-score and FE load capacity. The
vertical dashed line represents the DXA clinical standard at a T-score
of −1.0 and the horizontal dashed line represents the 75th percentile
FE load capacity cut-point at 3664N
Fig. 5 Application of the PRA model to determine fracture risk. Each
line reﬂects the distribution of loads for a speciﬁc mission with a
different exposure to gravity (e.g., ISS, Moon, Mars, and return to
Earth). Probabilities are based on an assessed NLF bone load
capacity equivalent to the NLF cut-point of 3664N. a The distribution
of loads expected to be applied to the hip for different missions for
low-energy events (loads between 1–4 kN). The probability of
experiencing an overloading event after return to Earth is 0.13
(e.g., tripping and falling). b Assessment of probability of fracture
using the NLF load capacity cut-point after a long-duration
spaceﬂight mission and return to Earth for high-energy events
(e.g., collision while playing football). The probability of experien-
cing an overloading event is 0.67
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collected and the modeling of applied hip loads enhanced, these
recommendations should be further reﬁned for speciﬁc mission
scenarios.
METHODS
Population DXA and QCT scanning
DXA and QCT scans were acquired from two separate population datasets
for this study: the AGES cohort47 and the Rochester Epidemiology
Project.27,48 Characteristics of both population cohorts can be referenced
in Table 1. Data from the AGES cohort was previously analyzed and
reported upon21,29 before inclusion in this study. From the AGES
population (N= 139), a cohort consisting of male subjects with hip
fracture were identiﬁed and approximately two age-matched non-
fractured cases were selected from the pool of subjects. All participants
provided written informed consent and the study was approved by the
respective institution review boards (i.e., National Bioethics Committee in
Iceland and the Institutional Review Board of the Intramural Research
Program of the National Institute on Aging).
For the AGES cohort, QCT scans of the hip were acquired using a four-
channel system (Sensation 4, Siemens Medical Systems, Erlangen,
Germany) as previously described.21,29 A standardized helical scanning
protocol (120 kVp, 140mAs, 1 mm image thickness, Pitch= 1, and 4mm
collimation) was used for all subjects, extending from ~1 cm superior to
the acetabulum to 5mm distal to the lesser trochanter of the left hip.
Within the scan ﬁeld-of-view for all subjects, a density calibration phantom
(Image Analysis, Columbia, KY, USA) was included to allow for Hounsﬁeld
Unit (HU) conversion to equivalent density values. No DXA data were
available from the AGES cohort.
The cohort from the Rochester Epidemiology Project,27,48 referred to as
the Mayo cohort, was determined from an age-stratiﬁed, random sample
of Rochester, MN, USA, and spans ages 27–90 years for a total of 397
participants. Fracture data in the Mayo cohort were not analyzed in the
present study, because few hip fractures occurred and because the
fracture deﬁnition was not appropriate for our study (e.g., low trauma
fractures were not distinguished from high trauma fractures).
Mayo DXA scans were performed using a single Lunar Prodigy System
(GE Healthcare, Madison, WI, USA) scanner following a standardized
scanning and analysis protocol, as previously reported.49 Hip QCT scans
were performed using a four-channel CT scanner (LightSpeed Qx/I, GE
Medical Systems, Waukesha, WI). A standardized imaging protocol
(120 kVp, 80 mA, 0.8 s rotation time, 0.75 pitch, 20 s scan time, 2.5 mm
image thickness, 7.5 mm/rotation table speed, and 10mm collimation) was
followed for all subjects.27 A density calibration phantom consisting of ﬁve
tubes containing various concentrations of K2HPO4 in water (Mindways
Model 3 Solid Calibration Phantom, Mindways Software, Inc., Austin, TX,
USA) was included in the scan ﬁeld-of-view for each subject for voxel-
speciﬁc HU conversion to K2HPO4 equivalent density.
Astronaut DXA and QCT scanning
Written informed consent was acquired from all astronauts whose data are
reported in this paper per a protocol approved by the Institutional Review
Board of NASA Johnson Space Center (Pro1531). As part of standard
operating procedures,11 all eight crewmembers received pre- and post-
ﬂight DXA scans of the hip using a Hologic Discovery whole body
densitometer (Hologic, Inc., Bedford, MA, USA). Scans were acquired on
average 95 ± 34 days before ﬂight and 8 ± 2 days after returning from
ﬂight. Both the left and right hips were scanned; however, only left hip
data are reported here, as the left hip was used in the analysis across all
components of this study. All DXA scans for an individual crewmember
were acquired on the same scanner and analyzed by the same operator to
ensure consistency. Scan acquisition procedures were performed as
recommended by the manufacturer; however, modiﬁcations to the
manufacturer’s analysis procedures were made, as previously described
for reported spaceﬂight and bedrest data.50 Precision of the manual
procedure is equivalent to that of the automated procedure available
using current DXA analysis software.
Crewmember QCT scans were obtained at a local hospital (Houston
Methodist St. John Hospital, Houston, TX, USA) using a single 64-channel
CT scanner (Lightspeed VCT, GE Medical Systems, Waukesha, WI, USA).
Astronauts provided informed consent in accordance with Institutional
Review Boards of the collaborating institutions (NASA Johnson Space
Center, University of California at San Francisco) for the collection of QCT
measurements. QCT scans were collected following a standardized
imaging protocol (140 kVp, 50 mA, 0.4 s rotation time, 0.984 pitch, 2.5
image thickness, and 40mm collimation). A density calibration phantom,
consisting of rods with concentrations of 0, 75, and 150mg/cc calcium
hydroxyapatite (Image Analysis, Columbia, KY, USA), was included in the
ﬁeld-of view for each scan to allow for voxel-speciﬁc HU conversion to
calcium hydroxyapatite equivalent density.
Crewmembers consented to have FE estimates of hip bone load
capacity, generated from their individual QCT scans, presented anon-
ymously to the FE Strength Task Group II. QCT scans were performed for
eight astronaut crewmembers who had also received DXA scans. Two QCT
hip scans were performed for each astronaut, one prior to launch at 82 ±
26 days and the second upon return from ﬂight at 10 ± 2 days. Six of the
eight astronaut crewmembers were involved with previous spaceﬂight
missions of varying durations (one long-duration spaceﬂight and ﬁve
short-duration spaceﬂights); however, due to privacy concerns, speciﬁc
details on previous length of spaceﬂight are not reported here, although
should be further investigated. All astronauts performed a standardized
Fig. 6 a Recommended standard operating procedure to integrate
QCT-FE into current pre-ﬂight monitoring standard operating
procedure. QCT-FE is to be used for a biomechanical assessment
of hip integrity. b Recommended standard operating procedure to
integrate QCT-FE into current post-ﬂight monitoring standard
operating procedure. QCT-FE is to be used as a comprehensive
index for monitoring post-ﬂight skeletal health recovery
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exercise plan on the ARED during spaceﬂight, but excluded astronauts
testing in-ﬂight use of a bisphosphonate pharmaceutical countermeasure.
Average time of ﬂight for astronauts was 154 ± 19 days. The data analyzed
and presented here are all from astronauts who are employed by NASA; no
data from cosmonauts or astronauts employed by the international space
agencies are reported in this manuscript.
DXA and QCT scanner cross-calibration
Multiple DXA scanners were used in the analysis of data presented here.
The Mayo cohort scans were performed using a Lunar Prodigy System,
while the astronaut scans were performed on a Hologic Discovery. In order
to compare the results of the two scanners, each scan was calibrated to the
Hologic BMD values using previously deﬁned linear equations.51,52
To ensure consistent measurements and to account for the use of
multiple CT scanners, all QCT scans included in the analysis were cross-
calibrated using an anthropometric hip phantom as previously
described.53 In short, a custom phantom, simulating the pelvic area of
the human body, was scanned on each independent CT scanner along
with the calibration phantom that was used when scanning subjects at
that site. Equivalent K2HPO4 or calcium hydroxyapatite densities derived
from each scan measurement were related to actual density measure-
ments of the anthropometric calibration phantom. These relationships
were then used to determine a cross-calibration relationship between the
calibrated equivalent density measurement on each of the scanners and
the calibrated equivalent calcium hydroxyapatite density on the scanner
for the AGES study. Each correction was then applied at the voxel level to
obtain adjusted equivalent density values.
QCT-FE analysis
FE analysis was performed for all subjects using standardized modeling
techniques in NLS and NLF loading conﬁgurations. The NLS loading
conﬁguration has been shown to be highly reliable in assessing hip load
capacity and in predicting fracture location,39,54 whereas NLF conﬁguration
simulates a conditional posterolateral fall on the hip. Both loading
conﬁgurations have previously been thoroughly described and validated
elsewhere.10,39,55–57 Brieﬂy, subject-speciﬁc geometry and isotropic hetero-
geneous material properties were derived from the calibrated and cross-
calibrated QCT density data. Each element of the model had nonlinear
material properties deﬁned by a density-dependent stress–strain curve
consisting of a linear elastic region to a yield point, a perfectly plastic
region, a strain softening region, and a second perfectly plastic region.39
Distortion energy failure theory was used as the yield criterion for model
elements. To determine load capacity, a displacement was incrementally
increased at the femoral head, whereas the distal femur was fully
constrained, until the reaction force at the femoral head began to
decrease. The load capacity was deﬁned as the maximum reaction
force.29,39 Least signiﬁcant change in load capacity outcome measures, as
previously reported, for NLS is 3.6% and for NLF is 11.3% (unpublished
data).
Statistical analysis
Statistical analyses were performed using R (v3.2.3, The R Foundation for
Statistical Computing, Vienna, Austria). Linear regression was used to
determine the coefﬁcient of determination (R2) between parameters. For
signiﬁcance testing, the criterion α-level was set to 0.05. Correlation p-
values were determined by testing the correlation coefﬁcient to be
different than zero (H0= 0). All absolute and relative changes are
presented as mean ± SD and range (minimum–maximum).
Software availability
All software used in this study has previously been reported, as cited in this
manuscript.
Reporting summary
Further information on experimental design is available in the Nature
Research Reporting Summary linked to this article.
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